European Atherosclerosis Society

The biological function of LPC in different cells promotes the formation of atherosclerotic plaques, aggravates inflammation, enhances anti-infective responses, regulates blood glucose, and affects the invasion and metastasis of tumors 🔗 https://lnkd.in/dttmxNEv #AtherosclerosisJournal #ATHJournal

Don’t miss our final EAS-LatAm webinar of the year! We’ve got an incredible lineup of speakers and can’t wait to share this experience with you. Be part of the closing event in this amazing series - register now before seats run out! https://lnkd.in/dDBSxT42

𝗥𝗶𝘀𝗶𝗻𝗴 𝘁𝗼 𝘁𝗵𝗲 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲: 𝘁𝗶𝗺𝗲 𝗳𝗼𝗿 𝗮𝗰𝘁𝗶𝗼𝗻 𝗼𝗻 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗵𝗲𝗮𝗹𝘁𝗵 📅 𝗗𝗮𝘁𝗲: 18 November 📍 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: The Hotel, Brussels 🎙 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: Permanent Representation of Hungary to the EU, Czech Deputy Ministry of Health, Patient Ambassadors, and more… Why should 𝗬𝗢𝗨 attend? ✅ Participate in discussions together with EU and national stakeholders on improving cardiovascular health (#CVH) in Europe ✅ Hear from patients why tackling #CVD is so important on a personal, social, and policy-level ✅ Network with our EACH partners and key policymakers in health policy afterwards during our reception This event is more than your usual conference, it’s a call to action to both Member States and the EU. Why should we waste any more valuable time? Let’s tackle the EU’s biggest killer of men and women together by turning talk into real change for #CVH Places are limited - don’t miss out on your spot and secure yours today. Register here: https://lnkd.in/eHvVyQtS #CVHealthForAll

These findings highlight changes in monocyte subset composition and activation, but not in the intrinsic migration capacity of AAV monocytes 🔗 https://lnkd.in/dSJqG_Yn #AtherosclerosisJournal #ATHJournal

🌟 So proud to be part of the #FHSC registry and the phenomenal Kausik Ray MD FMedSci team! 🚀 🧐Check out our latest study, exploring diabetes in individuals with #FH. We found that while statins are key in treating FH, #statins and #obesity are associated with prevalent #diabetes in this population 📌Even in the case of a genetic diagnosis, there’s no “protective effect” against diabetes. 👌Managing obesity is essential for better health outcomes! And more publications are on the way! 😉 https://lnkd.in/dK9ykA5T

The protein composition of the different HDL subpopulations is altered differentially in CHD patients. The functionality of the small and large HDL particles correlates with the protein content of APOA2 and APOE, respectively 🔗 https://lnkd.in/deRHHwtB #AtherosclerosisJournal #ATHJournal

Today EACH joins the world in supporting the International Day of Care and Support 🌍🤝   We would like to celebrate this day by highlighting work planned by the European Parliament Subcommittee on Public Health (SANT). SANT is preparing an upcoming INI (own-initiative procedure) report, which will focus on the sustainability of healthcare systems and an EU health workforce crisis plan.   Additionally, the European Commission funded a survey that was recently launched by WHO/Europe. The survey deals with the mental health and well-being of healthcare professionals across EU Member States, Iceland and Norway. The main goal is to gather data to better understand the challenges doctors and nurses face in their work environments. Find out more about it here: https://lnkd.in/eGY464sV   The resilience of the health workforce is crucial in providing #cardiovascular care. We believe every person affected by #CVD deserves compassionate and comprehensive care that addresses their unique needs. 💖   EACH reaffirms its commitments to ensuring that health systems across Europe are equipped and supported to deliver quality care to every patient, now and in the future. We therefore welcome Commissioner-Designate Várhelyi's commitments to more resilient health systems in his answers to written questions by Committees. 🩺 👇 https://lnkd.in/eYjhmDww   #CVHealthForAll

• HDL-C is associated w/ CHD risks in L-shaped manners among 👫 w/o diabetes, but U-shaped manners in 👫 w/ diabetes • Very large HDL-P showed inverted U-shaped associations w/ CHD risks in 👫 w/o diabetes, but linearly ➕ associations in 👫 w/ diabetes 🔗 https://lnkd.in/dvgXWHu2 #AtherosclerosisJournal #ATHJournal

Today is #WorldStrokeDay   The theme of this year’s campaign is the power of sport. 🏃 🏊♀️ ⚽   Did you know that 1 million strokes each year are linked to physical inactivity?   Exercising frequently throughout your week helps reducing several stroke risk factors, including hypertension, diabetes, depression, stress and cholesterol.   Although today is the last day to participate in the #GreaterThan Global Challenge, that does not mean you need to stop exercising! 😉 Do you want to reduce your risk of stroke by 25%? Get active with your favorite exercise 5 times a week for 30 minutes and start reducing your risk right away!   Learn more about stroke on https://lnkd.in/ep6kBMT   #Stroke #CVD #CVHealthForAll #GreaterThanStroke European Stroke Organisation Stroke Alliance For Europe (SAFE)

👆 Assessing the clinical potential of plozasiran, an APOC3 siRNA therapy for severe hypertriglyceridemia 👉 APOC3 siRNA therapy is an effective strategy for the treatment of severe HTG and prevention of TG-induced pancreatitis. Whether treatment with plozasiran translates into reduced ASCVD risk and mortality is unclear. Large-scale and long-term phase III studies in adults with refractory severe HTG and FCS will further evaluate the efficacy, safety, and durability and, importantly, help determine the cost effectiveness of plozasiran in such clinical settings. Moreover, Arrowhead has recently announced plans to initiate CAPITAN, a phase III cardiovascular outcomes trial of plozasiran 25 mg in adults with mixed hyperlipidemia and residual risk of ASCVD 🔓 Open Access https://lnkd.in/dUcwmS6R European Atherosclerosis Society